Your browser doesn't support javascript.
loading
Spontaneous remission of choroidal involvement by chronic myelomonocytic leukemia: a case report.
Diral, Elisa; Catalano, Gloria; Cicinelli, Maria Vittoria; Distefano, Andrea; Mastaglio, Sara; Vago, Luca; Lupo Stanghellini, Maria Teresa; Bernardi, Massimo; Ponzoni, Maurilio; Ciceri, Fabio; Carrabba, Matteo G.
Affiliation
  • Diral E; Department of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Catalano G; Vita-Salute San Raffaele University, Milan, Italy.
  • Cicinelli MV; Vita-Salute San Raffaele University, Milan, Italy.
  • Distefano A; Department of Ophthalmology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Mastaglio S; Vita-Salute San Raffaele University, Milan, Italy.
  • Vago L; Department of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Lupo Stanghellini MT; Department of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Bernardi M; Vita-Salute San Raffaele University, Milan, Italy.
  • Ponzoni M; Department of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Ciceri F; Department of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Carrabba MG; Vita-Salute San Raffaele University, Milan, Italy.
Front Oncol ; 14: 1399894, 2024.
Article in En | MEDLINE | ID: mdl-38756666
ABSTRACT
Chronic myelomonocytic leukemia (CMML) is a rare hematological disorder characterized by variable risk of evolution to acute myeloid leukemia; to date, allogeneic stem cell transplantation is the only curative treatment. We report a case of choroidal involvement in a woman affected by CMML and presenting only with visual impairment. The patient was initially evaluated for an intensive therapeutic approach, but after biopsy the ocular lesion spontaneously regressed. Thus a "watch and wait" strategy was preferred. One year and a half after initial diagnosis, the patient is alive, with stable hematological disease and without any ocular involvement. Therefore, a close, not invasive follow up could be useful to tailor treatment for patients affected by single ocular lesions in CMML.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Oncol Year: 2024 Type: Article Affiliation country: Italy

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Oncol Year: 2024 Type: Article Affiliation country: Italy